Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do no harm: a paradigm shift in the unchecked use of antidepressants.

CNS spectrums - 1 Apr 2017

Morrissette Debbi Ann

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Bipolar Disorder
Share to Comorbidity
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to Diagnostic Errors

Share to Guideline Adherence

Share to Mass Screening

Source

Identifiers

PMID: 28179047
DOI: 10.1017/S1092852917000086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do no harm: a paradigm shift in the unchecked use of antidepressants.PMID 28179047Read ↗

Benefits and risks of medications: challenges for the 21st century.Semantic proximity Read ↗

When good drugs go bad.Semantic proximity Read ↗

Fixed combinations of neuroleptics with antidepressants: potential risks and estimation of use.Semantic proximity Read ↗

Pharmacoepidemiology research: Drug therapy and drug safety in mental healthSemantic proximity Read ↗

One opioid does not fit all.Semantic proximity Read ↗

The future (or lack of future) of personalized prescription in psychiatrySemantic proximity Read ↗

Med-psych drug-drug interactions update.Semantic proximity Read ↗

Resetting priorities in precision medicine: the role of social prescribing.Semantic proximity Read ↗

Psychedelic Therapy: A Primer for Primary Care Clinicians—MescalineSemantic proximity Read ↗

NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?Semantic proximity Read ↗

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Verify the Efficacy and Safety of Ansofaxine (LY03005) for Major Depressive DisorderSemantic proximity Read ↗

UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.